Correlation Between Pasithea Therapeutics and GeoVax Labs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and GeoVax Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and GeoVax Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and GeoVax Labs, you can compare the effects of market volatilities on Pasithea Therapeutics and GeoVax Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of GeoVax Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and GeoVax Labs.

Diversification Opportunities for Pasithea Therapeutics and GeoVax Labs

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pasithea and GeoVax is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and GeoVax Labs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeoVax Labs and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with GeoVax Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeoVax Labs has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and GeoVax Labs go up and down completely randomly.

Pair Corralation between Pasithea Therapeutics and GeoVax Labs

Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to generate 6.41 times more return on investment than GeoVax Labs. However, Pasithea Therapeutics is 6.41 times more volatile than GeoVax Labs. It trades about 0.21 of its potential returns per unit of risk. GeoVax Labs is currently generating about 0.14 per unit of risk. If you would invest  1.67  in Pasithea Therapeutics Corp on September 3, 2024 and sell it today you would earn a total of  0.36  from holding Pasithea Therapeutics Corp or generate 21.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy63.54%
ValuesDaily Returns

Pasithea Therapeutics Corp  vs.  GeoVax Labs

 Performance 
       Timeline  
Pasithea Therapeutics 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Pasithea Therapeutics Corp are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Pasithea Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
GeoVax Labs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GeoVax Labs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pasithea Therapeutics and GeoVax Labs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pasithea Therapeutics and GeoVax Labs

The main advantage of trading using opposite Pasithea Therapeutics and GeoVax Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, GeoVax Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeoVax Labs will offset losses from the drop in GeoVax Labs' long position.
The idea behind Pasithea Therapeutics Corp and GeoVax Labs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
CEOs Directory
Screen CEOs from public companies around the world